AMR Threat to National Health Systems and Economies: A Call-to-Action

November 24, 2021 / New York, USA

During World Antimicrobial Awareness Week (WAAW), the Global Coalition on Aging (GCOA) hosted a live webinar and expert panel discussion, sponsored by Merck, titled, AMR Threat to National Health Systems and Economies: A Call-to-Action. The discussion centered around two recently published reports: the 2021 AMR Preparedness Index, a first-of-its-kind report created in partnership with the Infectious Disease Society of America (IDSA) and funded by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), and the London School of Economics’ Developing National Strategies to Tackle Antimicrobial Resistance across Countries in the Eastern Europe, Middle East and Africa (EEMEA) Region Report, which presents in-depth analysis of national action plans (NAPs) in Egypt, Russia, and South Africa.

The session featured introductory remarks from Paul Schaper (Merck) and Gemma Buckland Merrett (Wellcome Trust) and a preview of research findings from Dr. Michael Anderson (LSE). GCOA CEO Mike Hodin moderated a panel discussion with global AMR experts James Anderson (IFPMA), Amanda Jezek (IDSA) and Danielle Peterse (CAIC) on the steps governments must take to identify and address critical gaps in their AMR policies, secure greater funding for AMR initiatives and strengthen their overall AMR governance frameworks. At a time of growing global urgency around the AMR crisis, the GCOA session called for a renewed focus on AMR governance and decisive actions at the highest levels of government.

Key takeaways from the expert discussion include:

1. AMR and aging are inextricably linked. Increased resistance disproportionately impacts older adults, who are more susceptible to drug-resistant infections. The miracle of longevity is threatened by the lack of effective antibiotics.
2. Recent efforts from global decision makers have been ineffective in reviving the drug-development pipeline for new antimicrobials. Despite consensus on the need for robust pull incentives to stimulate antimicrobial development, most countries have not taken decisive action. Multilateral organizations have also failed to take sufficient ownership over this issue.
3. Countries must better support their national action plans. While many countries have crafted National Action Plans in recent years, many lack the sufficient funding to be properly implemented
4. Long-term thinking, broader ownership needed to effectively tackle AMR. We must find alternative approaches to improving national action plans that build in robust engagement from patients, civil society, and NGO’s to help drive implementation and accountability.
5. Awareness of the AMR crisis is low. Governments, experts and civil society must do more to ensure their populations understand the risk of AMR and the need for judicious use of antimicrobials.
6. AMR remains a complex and multifaceted challenge. Recent efforts by organizations like Wellcome Trust and WHO are helping to make the issue more widely understood.
7. An all-of-the-above approach is needed to tackle AMR. A One Health approach is key to addressing AMR. Countries must simultaneously jumpstart their broken antimicrobial development pipelines, strengthen stewardship programs, reduce misuse and overprescription, bolster surveillance and monitoring programs, raise overall awareness, improve access for those who need antimicrobials, and enhance environmental safeguards.

Watch the webinar below!


Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Brazil Must Fight Antibiotic Resistance

The threat posed by antimicrobial resistance is urgent and spares no country - including Brazil. According to The Lancet, 63 deaths per 100,000 are associated with AMR in Brazil and Paraguay, a rate that exceeds the average for Latin America and the Caribbean. AMR-associated deaths in Brazil are second only to cardiovascular diseases and cancers.

We Missed 100 Million Adult Vaccines – Here’s How We Get Back on Track

Like other pandemics throughout human history, COVID-19 has caused profound changes that are still rippling through our societies, even as people are understandably eager to move on. In fact, these impacts are all the more dangerous when they are largely ignored or effectively invisible. The decline in adult vaccination may be one of the most significant, as a new report finds that ~100 million doses were missed in 2021 and 2022 alone – reversing global progress towards widespread adult immunisation as a new standard of care in a world of more old than young.

New Analysis Shows Lost Ground on Adult Immunisation During the Pandemic with 100 Million Doses Potentially Missed

New data shared today by GSK, in collaboration with the IQVIA Institute for Human Data Science and the Global Coalition on Aging (GCOA), estimate approximately 100 million fewer doses of some adult vaccines (excluding Covid-19 vaccines) were administered in 2021 and 2022 than anticipated, based on the global vaccination adoption trends observed from 2013 to 2020, compounding already low adoption rates pre-pandemic.

Going Beyond Applause: The Potential of Caregiving to Unlock Job Opportunities of the Future

Early in the COVID-19 pandemic, the role of caregivers – staff and family who provide care for older and dependent people to carry out activities such as eating or moving - catapulted to the front of our collective conscience. The daily applause for front-line care workers showed a high level of recognition for their incredible work and provided insight into how our health systems must change as our society ages. We need to continue to recognise caregivers as essential to our ageing society.

High-Level Forum on the Silver Economy 2023

Join us for the High-Level Forum on the Silver Economy 2023. Now in its fourth year, the Silver Economy Forum 2023, December 6 and 7, will explore aging at every stage of life, looking at the growing global Silver Economy through a multigenerational lens. Linking to the goals and aspirations of the UN Decade of Healthy Ageing, SEF 2023 will highlight key themes at the intersection of aging at every age, and the Silver Economy.

Global Coalition on Aging Workshop Calls on G7 Countries to Fund Pull Incentives to Spur Antibiotic Innovation

The Global Coalition on Aging, in partnership with JPMA, today announced the release of its workshop report on the AMR crisis facing G7 countries and the world, “The Value of Pull Incentives in Japan to Encourage Investment in Antibiotic Innovation to Solve the AMR Crisis.” If strong action is not taken to address AMR, we will lose the antibiotics we need to cure infections, which is likely to outpace cancer as a major cause of death, killing an estimated 10 million by 2050.